Literature DB >> 15459394

Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis.

Emily A Partridge1, Christine Le Roy, Gianni M Di Guglielmo, Judy Pawling, Pam Cheung, Maria Granovsky, Ivan R Nabi, Jeffrey L Wrana, James W Dennis.   

Abstract

The Golgi enzyme beta1,6 N-acetylglucosaminyltransferase V (Mgat5) is up-regulated in carcinomas and promotes the substitution of N-glycan with poly N-acetyllactosamine, the preferred ligand for galectin-3 (Gal-3). Here, we report that expression of Mgat5 sensitized mouse cells to multiple cytokines. Gal-3 cross-linked Mgat5-modified N-glycans on epidermal growth factor and transforming growth factor-beta receptors at the cell surface and delayed their removal by constitutive endocytosis. Mgat5 expression in mammary carcinoma was rate limiting for cytokine signaling and consequently for epithelial-mesenchymal transition, cell motility, and tumor metastasis. Mgat5 also promoted cytokine-mediated leukocyte signaling, phagocytosis, and extravasation in vivo. Thus, conditional regulation of N-glycan processing drives synchronous modification of cytokine receptors, which balances their surface retention against loss via endocytosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15459394     DOI: 10.1126/science.1102109

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  273 in total

1.  Transcriptional regulation of the protocadherin β cluster during Her-2 protein-induced mammary tumorigenesis results from altered N-glycan branching.

Authors:  Huabei Guo; Alison Nairn; Mitche dela Rosa; Tamas Nagy; Shaying Zhao; Kelley Moremen; Michael Pierce
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  Golgi N-glycan branching N-acetylglucosaminyltransferases I, V and VI promote nutrient uptake and metabolism.

Authors:  Anas M Abdel Rahman; Michael Ryczko; Miyako Nakano; Judy Pawling; Tania Rodrigues; Anita Johswich; Naoyuki Taniguchi; James W Dennis
Journal:  Glycobiology       Date:  2014-10-01       Impact factor: 4.313

Review 3.  Protein biomarkers of ovarian cancer: the forest and the trees.

Authors:  Brian M Nolen; Anna E Lokshin
Journal:  Future Oncol       Date:  2012-01       Impact factor: 3.404

4.  Human plasma glycome in attention-deficit hyperactivity disorder and autism spectrum disorders.

Authors:  Nela Pivac; Ana Knezević; Olga Gornik; Maja Pucić; Wilmar Igl; Hilde Peeters; An Crepel; Jean Steyaert; Mislav Novokmet; Irma Redzić; Matea Nikolac; Vesna Novković Hercigonja; Katarina Dodig Curković; Mario Curković; Gordana Nedić; Dorotea Muck-Seler; Fran Borovecki; Igor Rudan; Gordan Lauc
Journal:  Mol Cell Proteomics       Date:  2010-10-25       Impact factor: 5.911

5.  Trafficking coordinate description of intracellular transport control of signaling networks.

Authors:  Jose M G Vilar; Leonor Saiz
Journal:  Biophys J       Date:  2011-11-15       Impact factor: 4.033

6.  Visualizing specific protein glycoforms by transmembrane fluorescence resonance energy transfer.

Authors:  Yoshimi Haga; Kumiko Ishii; Kayo Hibino; Yasushi Sako; Yukishige Ito; Naoyuki Taniguchi; Tadashi Suzuki
Journal:  Nat Commun       Date:  2012-06-19       Impact factor: 14.919

7.  In vivo deglycosylation of recombinant proteins in plants by co-expression with bacterial PNGase F.

Authors:  Tarlan Mamedov; Vidadi Yusibov
Journal:  Bioengineered       Date:  2013-01-17       Impact factor: 3.269

8.  Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells.

Authors:  Annick Lagana; Jacky G Goetz; Pam Cheung; Avraham Raz; James W Dennis; Ivan R Nabi
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 9.  The challenge and promise of glycomics.

Authors:  Richard D Cummings; J Michael Pierce
Journal:  Chem Biol       Date:  2014-01-16

10.  Candida albicans and Candida parapsilosis rapidly up-regulate galectin-3 secretion by human gingival epithelial cells.

Authors:  Riyoko Tamai; Yusuke Kiyoura
Journal:  Mycopathologia       Date:  2014-01-17       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.